Filing Details

Accession Number:
0001217234-21-000101
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-12 13:00:00
Reporting Period:
2021-05-10
Accepted Time:
2021-05-12 18:56:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1217234 Caredx Inc. CDNA Services-Medical Laboratories (8071) 943316839
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1366412 Michael Goldberg C/O Caredx, Inc.
1 Tower Place, 9Th Floor
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-10 15,442 $2.95 73,945 No 4 M Direct
Common Stock Disposition 2021-05-10 6,042 $66.78 67,903 No 4 S Direct
Common Stock Disposition 2021-05-10 183 $68.62 67,720 No 4 S Direct
Common Stock Disposition 2021-05-10 9,217 $70.36 58,503 No 4 S Direct
Common Stock Acquisiton 2021-05-11 49,083 $2.95 107,586 No 4 M Direct
Common Stock Disposition 2021-05-11 16,793 $65.83 90,793 No 4 S Direct
Common Stock Disposition 2021-05-11 16,308 $66.35 74,485 No 4 S Direct
Common Stock Disposition 2021-05-11 12,392 $67.49 62,093 No 4 S Direct
Common Stock Disposition 2021-05-11 3,590 $68.30 58,503 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2021-05-10 15,442 $2.95 15,442 $2.95
Common Stock Option to Purchase Common Stock Disposition 2021-05-11 49,083 $2.95 49,083 $2.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
49,083 2021-11-16 No 4 M Direct
0 2021-11-16 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.455 to $67.28, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.02 to $68.85, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.67 to $70.515, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $66.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.005 to $67.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.01 to $68.01, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.015 to $68.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  8. This option is subject to an early exercise provision and is immediately exercisable. 1/8th of the shares subject to the option vested on October 31, 2011 and 1/48th of the shares subject to the option vested monthly thereafter.